MORPHINE-6 GLUCURONIDE--DEVELOPMENT OF BREATHING CONTROL

吗啡-6 葡萄糖苷酸——呼吸控制的发展

• 批准号: 6137791
• 负责人: GEORGE D OLSEN
• 金额: $ 18.43万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1993
• 资助国家: 美国
• 起止时间: 1993-12-15 至 2001-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6137791
• 关键词: apnea; behavioral /social science research tag; brain stem; chronic disease /disorder; developmental neurobiology; drug abuse; drug metabolism; embryo /fetus toxicology; glucuronides; guanosine triphosphate; guinea pigs; morphine; neuropharmacology; newborn animals; opioid receptor; pharmacokinetics; receptor binding; receptor expression; respiration regulatory center; respiratory pharmacology; tissue /cell culture

The overall goal of this research is to examine the development of mu opioid receptors in the brainstem of the neonatal guinea pig in order to better understand the respiratory effects of chronic in utero morphine exposure and the role of morphine's active metabolite, morphine-6-beta-D-glucuronide (M6G), in respiratory depression. There are three main aspects to this proposal on the study of the mu opioid receptor that, when combined, make it unique. They are: 1) location, with the emphasis on the respiratory nuclei of the brainstem; 2) development, with the emphasis on the neonatal animal during the first week after birth; and 3) treatment, with the emphasis on chronic intermittent versus a constant rate of in utero morphine exposure. The anatomical studies include the localization and quantitation of mu opioid receptors and receptor mRNA using immunohistochemistry, autoradiography, in situ hybridization and reverse transcriptase polymerase chain reaction (RT-PCR); the pharmacological studies include characterization of binding profiles of brainstem membranes and stably transfected CHO cells; and the functional studies include the determination of opioid-induced GTPgammaS binding in tissue and cells. These studies will provide new information about the role of mu receptors in development, morphine-induced respiratory depression, and importantly, the relationship of M6G binding (to mu and to a potential atypical site) in morphine-induced respiratory effects. The hypotheses are: 1) that there are developmental changes in D- Ala2-MePhe4-Gly-ol5-enkephalin (DAMGO) binding and opioid-induced GTPgammaS binding in brainstem respiratory nuclei during the first week of life; 2) that developmental changes in the mu opioid receptor are affected by in utero morphine exposure; and 3) that there are quantitative and qualitative differences between [3H]-DAMGO and [3H]-M6G binding and opioid-induced GTPgammaS binding in the brainstem during postnatal development and following in utero morphine exposure. Changes in opioid receptors associated with respiratory nuclei have consequences for the effects of morphine and M6G on breathing. This study is of significance for the fetus and neonate who are exposed in utero to heroin or other opioids because of maternal drug abuse, maintenance therapy of pregnant former opioid abusers or pain therapy.

本研究的总体目标是研究新生豚鼠脑干内Mu阿片受体的发育，以更好地了解宫内慢性吗啡暴露对呼吸的影响以及吗啡的活性代谢物吗啡-6-β-D-葡萄糖醛酸苷(M6G)在呼吸抑制中的作用。这项关于Mu阿片受体研究的建议主要有三个方面，当结合在一起时，它就变得独特了。它们是：1)定位，重点是脑干的呼吸核团；2)发育，重点是出生后第一周的新生动物；3)治疗，重点是慢性间歇性接触吗啡，而不是子宫内恒定的吗啡暴露。解剖学研究包括利用免疫组织化学、放射自显影、原位杂交和逆转录聚合酶链式反应(RT-PCR)对MU阿片受体和受体mRNA进行定位和定量；药理学研究包括表征脑干膜和稳定转染的CHO细胞的结合谱；功能研究包括测定阿片类药物诱导的组织和细胞中GTPGammaS的结合。这些研究将提供有关Mu受体在发育中的作用，吗啡诱导的呼吸抑制，以及重要的是，M6G结合(与Mu和潜在的非典型位点)在吗啡诱导的呼吸效应中的关系的新信息。假设：1)脑干呼吸核团D-Ala2-MePhe4-Gly-5-Enkephin(DAMGO)结合和阿片类药物诱导的GTP-GammaS结合在出生后第一周有发育变化；2)u阿片受体的发育变化受宫内吗啡暴露的影响；3)出生后发育和子宫内吗啡暴露后脑干[~3H]-DAMGO和[~3H]-M6G结合和阿片诱导的GTP-GammaS结合存在数量和质量上的差异。与呼吸核团相关的阿片受体的变化与吗啡和M6G对呼吸的影响有关。本研究对因母亲滥用药物而在宫内暴露于海洛因或其他阿片类药物的胎儿和新生儿，对孕期前阿片类药物滥用者的维持治疗或疼痛治疗具有重要意义。